Cargando…

Expression, Localization, and Phosphorylation of Akt1 in Benign and Malignant Thyroid Lesions

The serine/threonine protein kinase Akt is a key molecule in the phosphatidyl inositol 3-kinase pathway that is often overactivated in human cancers. Three Akt isoforms (Akt1, Akt2, Akt3) have been identified in human cells and they show different distribution and have non-redundant functions. The a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krześlak, Anna, Pomorski, Lech, Lipińska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229690/ https://www.ncbi.nlm.nih.gov/pubmed/21898122 http://dx.doi.org/10.1007/s12022-011-9177-4

Ejemplares similares

Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions
por: Jóźwiak, Paweł, et al.
Publicado: (2017)

Radiofrequency for benign and malign thyroid lesions
por: Rangel, Leonardo, et al.
Publicado: (2020)

Role of metallothioneins in benign and malignant thyroid lesions
por: Pula, Bartosz, et al.
Publicado: (2012)

Role of morphometry in the cytological differentiation of benign and malignant thyroid lesions
por: Khatri, Pallavi, et al.
Publicado: (2017)

Fra-1 Expression in Malignant and Benign Thyroid Tumor
por: Kim, Yong-Hyun, et al.
Publicado: (2001)

Caveolin-1 expression in benign and malignant lesions of the breast
por: Liedtke, Cornelia, et al.
Publicado: (2007)

Radiomics Nomogram for Identifying Sub-1 cm Benign and Malignant Thyroid Lesions
por: Wu, Xinxin, et al.
Publicado: (2021)

Patterns of Benign and Malignant Lesions of the Thyroid in Two Wilayahs of Northeastern Algeria
por: Guidoum, Mona, et al.
Publicado: (2015)

Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland
por: Bankir, Mehmet, et al.
Publicado: (2020)

Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions
por: Lakiotaki, Eleftheria, et al.
Publicado: (2015)

Relationship between polycomb‐group protein BMI‐1 and phosphatases regulating AKT phosphorylation level in endometrial cancer
por: Zaczek, Agnieszka, et al.
Publicado: (2019)

Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions
por: Bariya, Deepak, et al.
Publicado: (2022)

Benign and malignant thyroid nodules with autoimmune thyroiditis
por: Kassi, Georgia N., et al.
Publicado: (2022)

Receptor-Binding Cancer Antigen expressed on SiSo cells (RCAS1) expression in human benign and malignant thyroid lesions
por: Giaginis, Constantinos, et al.
Publicado: (2012)

Expression of pendrin in benign and malignant human thyroid tissues
por: Skubis-Zegadło, J, et al.
Publicado: (2005)

Influence of lesion size on shear wave elastography in the diagnosis of benign and malignant thyroid nodules
por: Li, Huizhan, et al.
Publicado: (2021)

Glucose and Cell Context-Dependent Impact of BMI-1 Inhibitor PTC-209 on AKT Pathway in Endometrial Cancer Cells
por: Zaczek, Agnieszka, et al.
Publicado: (2022)

Evaluation of NDRG2 gene expression in primary papillary thyroid carcinoma and in metastases of this neoplasm to regional lymph nodes
por: Mordalska, Anna, et al.
Publicado: (2010)

Genetic Heterogeneity of Benign Thyroid Lesions
por: Ferrer-Roca, O., et al.
Publicado: (1998)

Expression of tropomyosin isoforms in benign and malignant human breast lesions.
por: Franzén, B., et al.
Publicado: (1996)

Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: An immunohistochemical study
por: Karidis, Nikolaos P., et al.
Publicado: (2011)

Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: An immunohistochemical study
por: Giaginis, Constantinos, et al.
Publicado: (2011)

The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions
por: Terry, G, et al.
Publicado: (2007)

Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
por: Zaremba, Anne, et al.
Publicado: (2022)

One-step nucleic acid amplification analysis of sentinel lymph nodes in papillary thyroid cancer patients
por: Kaczka, Krzysztof A., et al.
Publicado: (2017)

Benign Mesenteric Lesion Presenting with Features of a Malignant Mass
por: Principe, Josefina, et al.
Publicado: (2023)

Sentinel lymph node in thyroid tumors – own experience
por: Kaczka, Krzysztof, et al.
Publicado: (2013)

Comparative Expression of RAGE and SOX2 in Benign and Malignant Prostatic Lesions
por: Aboushousha, Tarek, et al.
Publicado: (2019)

Role of CD10 Marker in Differentiating Malignant Thyroid Neoplasms from Benign Thyroid Lesions (Immunohistochemical & Histopathological Study)
por: Gabal, Samia Mohamed, et al.
Publicado: (2018)

Quantitative Analysis of Galectin-3 Expression in Benign and Malignant Thyroid Nodules
por: Šamija, Ivan, et al.
Publicado: (2020)

Diagnostic Snapshot: Aggressive Malignancy or Benign Lesion?
por: Goforth, Paige M.
Publicado: (2014)

A Prospective Study to Evaluate the Reliability of Thyroid Imaging Reporting and Data System in Differentiation between Benign and Malignant Thyroid Lesions
por: Srinivas, M Naren Satya, et al.
Publicado: (2016)

Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue
por: Kachel, Paul, et al.
Publicado: (2015)

Differential Protein Expression Profiles of Cyst Fluid from Papillary Thyroid Carcinoma and Benign Thyroid Lesions
por: Dinets, Andrii, et al.
Publicado: (2015)

Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study
por: Tőkés, Anna-Mária, et al.
Publicado: (2005)

Role of Multiparameter Analysis of AgNORs in FNA Smears of Thyroid Swellings in Differentiating Benign and Malignant Lesions
por: Hossain, Mohammad Ismail, et al.
Publicado: (2012)

Differential Expression of HER2 and SKP2 in Benign and Malignant Colorectal Lesions
por: Moussa, Mona, et al.
Publicado: (2020)

Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance
por: Wang, Lingxiang, et al.
Publicado: (2018)

Shared and unique metabolic features of the malignant and benign thyroid lesions determined with use of (1)H HR MAS NMR spectroscopy
por: Skorupa, Agnieszka, et al.
Publicado: (2021)

Thyroid function in patients with benign and malignant breast disease.
por: MacFarlane, I. A., et al.
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_fhs6n6bun6etsfoqh9s1k3nm4p